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Introduction
The intestinal epithelium is constantly and rapidly renewing 
throughout the lifespan of vertebrates, thereby representing a 
major target for tumorigenesis. This epithelium can be di-
vided into two functionally distinct compartments. The crypt of 
  Lieberkühn constitutes the proliferative compartment and con-
tains stem/progenitor cells, as well as, in the small intestine, ter-
minally differentiated Paneth cells. Multipotent stem cells, 
located near the bottom of crypts, generate new cells, which mi-
grate upwards while differentiating into enterocytes, goblet, and 
enteroendocrine cells. Proliferation stops at the crypt–villus 
junction, and terminally differentiated cells are located on the 
neighboring villus, which constitute the differentiated compart-
ment. In the small intestine, a fourth cell type, the Paneth cell, 
migrates downward and settles at the bottom of the crypts as 
postmitotic, differentiated cells. The balance among prolifera-
tion, differentiation, migration, and cell death must be tightly 
regulated to maintain homeostasis of this epithelium.
We reported the expression of Sox9, an HMG-box tran-
scription factor, specifi  cally, in the rapidly proliferating stem/
progenitor cells found at the bottom third of Lieberkühn crypts 
throughout the length of the intestine and in the Paneth cells of 
the small intestine, as well as in human tumors of the intestinal 
epithelium (Blache et al., 2004). Sox9 was fi  rst identifi  ed as a 
key regulator of cartilage and male gonad development. Hetero-
zygous Sox9 mutations are responsible for the campomelic 
  dysplasia syndrome, a skeletal dysmorphology syndrome char-
acterized by skeletal malformation of endochondral bones and 
by male-to-female sex reversal in the majority of genotypically 
XY individuals (Foster et al., 1994; Wagner et al., 1994). Sox9 
has also been implicated in the development of cranial neural 
crest derivatives (Spokony et al., 2002), in the neural stem cell 
switch from neurogenesis to gliogenesis (Stolt et al., 2003) and 
in heart (Akiyama et al., 2004a), hair (Vidal et al., 2005), and 
pancreas (Seymour et al., 2007) development. In each of these 
tissues, Sox9 expression is restricted to specifi  c cell types, sug-
gesting a complex transcriptional regulation. In addition, the 
currently identifi  ed Sox9 target genes, for instance, in the cartilage 
and in the gonad, display tissue-specifi  c expression (Ng et al., 
1997; de Santa Barbara et al., 1998), indicating that Sox9 may 
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T
he HMG-box transcription factor Sox9 is expressed 
in the intestinal epithelium, speciﬁ  cally, in stem/ 
progenitor cells and in Paneth cells. Sox9 expression 
requires an active β-catenin–Tcf complex, the transcrip-
tional effector of the Wnt pathway. This pathway is critical 
for numerous aspects of the intestinal epithelium physio-
pathology, but processes that specify the cell response to such 
multipotential signals still remain to be identiﬁ  ed. We in-
activated the Sox9 gene in the intestinal epithelium to ana-
lyze its physiological function. Sox9 inactivation affected 
differentiation throughout the intestinal epithelium, with a 
disappearance of Paneth cells and a decrease of the gob-
let cell lineage. Additionally, the morphology of the colon 
epithelium was severely altered. We detected general 
  hyperplasia and local crypt dysplasia in the intestine, and 
Wnt pathway target genes were up-regulated. These re-
sults highlight the central position of Sox9 as both a tran-
scriptional target and a regulator of the Wnt pathway in 
the regulation of intestinal epithelium homeostasis.
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regulate distinct sets of genes in the different tissues in which it 
is expressed.
In the intestinal epithelium, the function of Sox9 remains 
unresolved, although in vitro studies suggested a role in the 
control of cell differentiation (Blache et al., 2004). In vitro and 
in vivo data indicate that Sox9 is a transcriptional target of Wnt 
signaling. For instance, Sox9 expression is abrogated in Tcf4-
null embryos, and it is strongly expressed in colorectal carci-
noma cell lines containing activating mutations in components 
of the Wnt pathway (Blache et al., 2004).
The Wnt pathway plays a central role among the extra-
cellular signals required to maintain the homeostasis of the intesti-
nal epithelium. In particular, deletion of the gene encoding Tcf4, 
another HMG-box transcription factor (Korinek et al., 1998), or 
overexpression of the inhibitor Dickkopf (Pinto et al., 2003; 
Kuhnert et al., 2004), resulted in a loss of the proliferative com-
partment and in impaired differentiation of secretory cell line-
ages. Conversely, mutation of the gene encoding Apc, a negative 
regulator of the pathway, resulted in crypt expansion, abrogation 
of cell migration, and amplifi  cation of the Paneth cell popula-
tion (Sansom et al., 2004; Andreu et al., 2005). In addition, dele-
tion of the Wnt receptor Frizzled-5 revealed an essential role of 
the Wnt–Frizzled-5 pathway in the maturation of Paneth cells 
(van Es et al., 2005). The sorting process of epithelial cells along 
the crypt–villus axis also depends on the Wnt pathway, via a 
modulation of Ephrin–Eph receptor interactions (Batlle et al., 
2002). The Wnt signaling pathway can thus induce diverse cel-
lular responses in the intestinal epithelium. In addition to these 
physiological functions, the Wnt pathway is centrally implicated 
in cancer, as mutations in components of this pathway have been 
identifi  ed in the majority of human colorectal carcinoma (Morin 
et al., 1997). Such mutations mimic activation of the pathway by 
Wnt ligands (i.e., stabilization of β-catenin) and result in consti-
tutive transcriptional activity of the β-catenin–Tcf4 complex and 
in aberrant expression of its target genes (Korinek et al., 1997). 
Despite the central importance of this pathway in the physio-
pathology of the intestinal epithelium, little is known about 
the molecular mechanisms involved in restricting this wide 
spectrum of potential functions to elicit a specifi  c and adequate 
response from Wnt-stimulated cells.
The fact that Sox9 is transcriptionally regulated by the 
β-catenin–Tcf4 complex (Blache et al., 2004), together with the 
particular expression of Sox9 in the compartment of the intesti-
nal epithelium that contains Wnt-stimulated cells, suggests dis-
tinct functions in proliferating stem/progenitor cells and in the 
postmitotic Paneth cells (Fig. S1 A, available at http://www.jcb
.org/cgi/content/full/jcb.200704152/DC1). To address the dif-
ferent aspects of Sox9 function during the turnover of the intes-
tinal epithelium, including its possible role in specifying the 
cell response to Wnt signals, we specifi  cally inactivated the cor-
responding gene in the intestinal epithelium.
Results
Generation of mice with a Sox9-deﬁ  cient 
intestinal epithelium
To analyze the function of Sox9 in the turnover of the adult 
intestinal epithelium, Villin-Cre (vil-Cre) mice, in which the Cre 
recombinase is expressed specifi  cally in the intestinal epithe-
lium from 10.5 d postcoitum onward (el Marjou et al., 2004) 
were crossed with Sox9
fl  ox/fl  ox (Kist et al., 2002) mice, which 
have both Sox9 alleles fl  anked by loxP sequences. This gener-
ated Sox9
fl  ox/fl  ox-vil-Cre mice, with an intestinal epithelium 
lacking Sox9 protein, indicating effective vil-Cre–mediated 
  recombination of the Sox9
fl  ox allele (Fig. 1). The control vil-Cre 
mice had no detectable phenotypic defect. Sox9
fl  ox/fl  ox-vil-Cre 
mice developed as their control littermates (Sox9
flox/flox or 
Sox9
fl  ox/wt-vil-Cre) to become healthy and fertile adult mice. No 
evidence for intestinal bleeding was found.
Sox9 inactivation causes aberrant 
morphology and decreased goblet 
cell lineage in the colon
Histological analysis of the intestine from 2–6-mo-old adult 
Sox9
fl  ox/fl  ox-vil-Cre mice revealed that, although the overall mor-
phology of the small intestine seemed, at fi  rst sight, unaffected 
(Fig. 2, a and b), that of the colon was aberrant. The most strik-
ing feature of the Sox9
fl  ox/fl  ox-vil-Cre mice colon was the folding 
of the epithelium into villus-like structures, protruding into the 
colon lumen, reminiscent of the small intestine morphology 
(Fig. 2, c–f; and Fig. S1, B–D). Proliferation, however, was ad-
equately restricted to the bottom half of the crypts in Sox9
fl  ox/fl  ox-
vil-Cre mice, as assessed by Ki67 staining (Fig. 2, g and h).
We then examined the differentiation pattern of the 
Sox9
flox/flox-vil-Cre mice colon epithelium into the three main 
types of differentiated colon epithelial cells. Among these, 
Figure 1.  Absence of Sox9 protein expression in the intestinal epithelium of 
Sox9-deﬁ  cient mice. In Sox9
ﬂ  ox/ﬂ  ox mice, the Sox9 protein is expressed in the 
bottom of small intestinal (a) and colon (c) crypts. The absence of speciﬁ  c 
Sox9 staining in the small intestine (b) and colon (d) from Sox9
ﬂ  ox/ﬂ  ox-vil-Cre 
mice demonstrate efﬁ  cient vil-Cre–mediated recombination. Arrows and 
arrowheads indicate Sox9-positive and -negative nuclei, respectively. Bars: 
(panels) 150 μm; (insets) 50 μm.SOX9–WNT INTERACTION CONTROL INTESTINAL HOMEOSTASIS • BASTIDE ET AL. 637
mucus-producing goblet cells represent the largest population and 
are responsible for epithelium protection and lubrication (Velcich 
et al., 2002). Most of the other cells are enterocytes, with few 
interspersed enteroendocrine cells. Alcian blue and Muc2 
stainings showed that the goblet cell population was strongly 
decreased in the colon of Sox9-defi  cient animals (Fig. 3, a–d). 
No differences were detected in the morphology or staining 
  intensity between individual alcian blue–positive goblet cells 
in Sox9
fl  ox/fl  ox and Sox9
fl  ox/fl  ox-vil-Cre mice, and no changes in 
cellular representation were found either for the scarce entero-
endocrine cell population (Fig. 3, e and f) or for the Cdx2-
  expressing enterocyte population (Fig. 3, g and h). Thus, Sox9 
is involved in defi  ning the colon epithelium morphology and 
plays a specifi  c role in the differentiation of the goblet cell lineage 
in the colon.
Figure 2.  Morphological alterations in the colon of Sox9-deﬁ  cient mice. 
Histological analysis (hematoxylin staining) of the intestine of Sox9
ﬂ  ox/ﬂ  ox 
(a, c, and e) and Sox9
ﬂ  ox/ﬂ  ox-vil-Cre mice (b, d, and f). The gross morphol-
ogy of the small intestine of the Sox9
ﬂ  ox/ﬂ  ox-vil-Cre mice is not affected 
(a and b), whereas that of the colon is strongly altered. The surface of the 
colon is normally ﬂ  at (c and e, arrows), but villus-like structures protrude 
into the lumen of the colon of Sox9
ﬂ  ox/ﬂ  ox-vil-Cre mice (d and f, arrows). 
  Immunohistochemical staining with the Ki-67 proliferation in Sox9
ﬂ  ox/ﬂ  ox mice 
(g) and Sox9
ﬂ  ox/ﬂ  ox-vil-Cre mice (h) indicates appropriate crypt-restricted 
proliferation in the colon of Sox9-deﬁ  cient animals. Bars, 150 μm.
Figure 3.  Altered goblet cell differentiation in the colon of Sox9-deﬁ  cient 
mice. Immunohistochemical analysis of Sox9
ﬂ  ox/ﬂ  ox mice (a, c, e, and g) 
and Sox9
ﬂ  ox/ﬂ  ox-vil-Cre mice (b, d, f, and h). Alcian blue staining (a and b) 
and Muc2 immunoreactivity (c and d) reveal a strong reduction of the 
  goblet cell population in the colon epithelium of Sox9
ﬂ  ox/ﬂ  ox-vil-Cre mice. 
Sox9
ﬂ  ox/ﬂ  ox and Sox9
ﬂ  ox/ﬂ  ox-vil-Cre mice have comparable populations of 
chromogranin A–positive enteroendocrine cells (e and f) and Cdx-2–positive 
enterocytes (g and h). Bars, 150 μm.JCB • VOLUME 178 • NUMBER 4 • 2007  638
Sox9 is required for Paneth 
cell differentiation
When we examined the expression of markers representative of the 
four main cell lineages constituting the small intestinal epithelium, no 
major differences were found in enterocyte and enteroendocrine cell 
numbers, as shown by alkaline phosphatase and chromogranin A 
staining (Fig. 4, a–d). However, both the goblet and Paneth cell lin-
eages were considerably affected.   Alcian blue–positive goblet cells 
were found in the Sox9
fl  ox/fl  ox-vil-Cre intestinal epithelium and ap-
propriately expressed Muc2, but their number was reduced by 40% 
compared with control mice (Fig. 4, e–h; and Fig. S2, A and B, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200704152/DC1).
Figure 4.  Sox9 controls differentiation of the Paneth and goblet cell lineages. Sox9
ﬂ  ox/ﬂ  ox (a, c, e, g, i, k, and m) and Sox9
ﬂ  ox/ﬂ  ox-vil-Cre (b, d, f, h, j, l, and n) 
mice are compared. Differentiation along the enterocyte (a and b) and enteroendocrine (c and d) lineages is not affected. The goblet cell population, 
revealed by alcian blue staining for acidic mucins (e and f) and Muc2 immunostaining (g and h), is reduced in the small intestinal epithelium of Sox9-deﬁ  cient 
mice.   Paneth cells (arrows in control mice) are completely absent (arrows) in Sox9-deﬁ  cient crypts (i and j). Instead, the proliferative compartment (k–n, 
arrows)   expands to occupy the whole crypt bottom in mutant animals, where more Musashi-1–expressing putative stem cells are found (o and p, arrows). 
Ectopic   Paneth cell found in a human patient with Barrett’s esophagus (intestinal metaplasia in the esophagus) also express Sox9, as shown by staining of 
adjacent sections with lysozyme (q) and Sox9 (r) antibodies. Expression analysis of the Paneth cell markers lysozyme, MMP7, and Angiogenin-4, in the 
HT29Cl.16E-Sox9 cell line, before and after doxycycline induction of exogenous Sox9 expression (s). Bars: (a–l, q, and r) 120 μm; (m and n) 30 μm; 
(o and p) 40 μm.SOX9–WNT INTERACTION CONTROL INTESTINAL HOMEOSTASIS • BASTIDE ET AL. 639
Paneth cells represent the fourth cell type found in the 
small intestine. They secrete a variety of products, including 
antimicrobial peptides, growth factors, phospholipase A2, and 
matrilysin. These cells are involved in regulating the inter-
actions between epithelial cells and the indigenous microorgan-
ism population, which, in turn, is essential to elaborate the 
microvasculature underlying the epithelium (Wilson et al., 
1999; Stappenbeck et al., 2002). Remarkably, morphological 
identifi  cation coupled with staining of small intestinal sections 
from Sox9
fl  ox/fl  ox-vil-Cre mice for lysozyme, an early marker of 
Paneth cell differentiation, revealed that almost all the crypts 
were completely devoid of Paneth cells (Fig. 4, i and j). In Pan-
eth cell–depleted crypts, the proliferative compartment ex-
panded to occupy the whole crypt base, including the normal 
Paneth cell compartment (Fig. 4, k–n). As Paneth cells are lo-
cated next to the putative stem cells, the replacement of Paneth 
cells by proliferating cells raises the possibility that the number 
of stem cells is altered in Sox9-defi  cient mice. Indeed, the num-
ber of cells positively stained with Musashi-1, a putative marker 
of stem cells in the nervous system and the intestinal epithelium 
(Sakakibara et al., 1996; Potten et al., 2003), was increased in 
Sox9-defi  cient mice (Fig. 4, o and p). Sox9 is thus required for 
differentiation of the Paneth cell lineage, is involved in differen-
tiation of the goblet cell lineage, and might be involved in the 
regulation of the stem cell number. The observed decrease in 
Paneth and goblet lineages in Sox9-defi  cient mice was not due 
to increased apoptosis, as no differences were found in the 
apoptotic rates between Sox9
fl  ox/fl  ox-vil-Cre and Sox9
fl  ox/fl  ox mice 
(Fig. S2 C).
In the healthy human body, Paneth cells are also found 
uniquely in the small intestinal crypts of Lieberkühn. In some 
pathological situations, such as intestinal metaplasia, ectopic 
Paneth cells can also be found in the esophagus (Barrett’s 
esophagus) or in the stomach (Schreiber et al., 1978). Thus, if 
Sox9 is required for the differentiation of the Paneth cell lin-
eage, it should be expressed in Paneth cells found in such aber-
rant structures. To test this, we analyzed biopsy sections from a 
patient with Barrett’s esophagus. Paneth cells were detected us-
ing lysozyme expression, and Sox9 expression was analyzed on 
an adjacent section. Sox9 expression was found in most cells 
constituting crypt-like structures in the metaplasic area, includ-
ing Paneth cells (Fig. 4, q and r). Thus, Sox9 expression also 
seems to be associated with Paneth cells in the pathological 
context of human intestinal metaplasia.
To gain insight into the mechanism underlying the Sox9-
dependent differentiation of Paneth cells, we screened by real-
time PCR colon carcinoma cell lines for expression of Paneth 
cell markers. All the tested cell lines (SW480, HT29Cl.16E, 
HCT116, and DLD-1) had detectable expression of such mark-
ers, and this expression was highest in HT29Cl.16E cells 
  (unpublished data), which were chosen for further analyses. 
A moderate (fi  vefold) overexpression of Sox9 in these cells 
  resulted in an up-regulation of expression of several Paneth cell 
markers, which was most prominent for lysozyme, the matrix 
metalloproteinase MMP7, and Angiogenin-4 (ANG-4) mRNAs 
(Fig. 4 s). Thus, Sox9 may regulate the differentiation of Paneth 
cells, at least in part, through the transcriptional regulation of 
Figure 5.  Generalized hyperplasia develops in the absence of Sox9. 
  Difference of crypt size in the small intestines of Sox9
ﬂ  ox/ﬂ  ox (a and c) and 
Sox9
ﬂ  ox/ﬂ  ox-vil-Cre (b and d) mice. (a and b) Crypt cross sections; (c and d) 
crypt longitudinal sections. Bars, 75 μm. (e) Histogram showing mean crypt 
diameters along the small intestines of three Sox9
ﬂ  ox/ﬂ  ox and three Sox9
ﬂ  ox/ﬂ  ox-
vil-Cre mice. Standard deviations are indicated. P < 0.001 (t test). (f) Histogram 
showing the BrdU incorporation rates (number of BrdU-positive cells/total 
number of cells) in crypts from three Sox9
ﬂ  ox/ﬂ  ox and three Sox9
ﬂ  ox/ﬂ  ox-vil-Cre 
mice. Standard deviations are indicated. P < 0.001 (t test).JCB • VOLUME 178 • NUMBER 4 • 2007  640
several markers of these cells. This regulation might be direct or 
indirect, but it likely contributes to the absence of identifi  able 
Paneth cells in the intestinal epithelium of Sox9-defi  cient mice.
Increased cell proliferation and hyperplasia 
throughout the intestinal epithelium 
of Sox9-deﬁ  cient mice
We then asked whether the homeostasis of the epithelium would 
be conserved despite the extension of the proliferative compart-
ment into the usual Paneth cell area and found that, in fact, the 
crypt size of Sox9
fl  ox/fl  ox-vil-Cre mice seemed increased com-
pared with Sox9
flox/flox control mice (Fig. 5, a–d). When crypt 
  diameters and BrdU incorporation rates were measured, an un-
ambiguous increase of crypt size was found in Sox9-defi  cient 
mice (Fig. 5 e), and the ratio between BrdU-labeled cells and the 
total number of cells found in a crypt circumference was slightly, 
but reproducibly, increased in the Sox9-defi  cient mice (Fig. 5 f). 
This was statistically signifi  cant (P < 0.0001). The total number 
of cells in any crypt circumference increased according to the 
crypt size, indicating that the cell size was not affected (unpub-
lished data). This indicates that the absence of Sox9 resulted in 
increased cell proliferation, leading, in turn, to crypt hyperplasia 
throughout the small intestine. The epithelium from the proxi-
mal colon was also found to display hyperplastic features, but 
Figure 6.  Sox9 deﬁ  ciency causes hyperplasia and dysplasia. In the colon epithelium of Sox9
ﬂ  ox/ﬂ  ox-vil-Cre mice, hyperplastic lesions are found (hematoxy-
lin staining) with branched and enlarged crypts (a). Some crypts have a cystic appearance (b). Such structures proliferate (c and d, arrows). Tubulovillous 
microadenomas spontaneously developed in hyperplastic areas of Sox9
ﬂ  ox/ﬂ  ox-vil-Cre mice (e). Typical example of the dysplastic-looking crypts (arrows) 
found in the distal half of the colon of Sox9-deﬁ  cient mice. Arrowheads point at mutiadenoid crypts (f). Compared with normal tissue (g, i, and k), hyper-
plastic and dysplastic crypts of Sox9-deﬁ  cient mice (h, j, and l) overexpress Wnt pathway target genes such as c-Myc (compare g and h) and cyclin D1 
(compare i and j) and, accordingly, have elevated staining for the Ki67 proliferation marker (compare k and l). Insets in panels g–l show enlarged pictures 
of the indicated area of the panel, and arrows point at typical staining pictures. Western blot analysis of c-Myc, cyclin D1, and PCNA in the small intestine 
and colon of Sox9
ﬂ  ox/ﬂ  ox and Sox9
ﬂ  ox/ﬂ  ox-vil-Cre mice. β-Actin expression is shown as a loading control (m). Stool hydration is increased in Sox9-deﬁ  cient 
mice (n). Bars: (panels) 150 μm; (insets) 50 μm.SOX9–WNT INTERACTION CONTROL INTESTINAL HOMEOSTASIS • BASTIDE ET AL. 641
we were unable to perform accurate measurements because of 
its severely altered morphology in Sox9
fl  ox/fl  ox-vil-Cre mice.
Focal dysplastic crypts spontaneously 
develop in the colon of Sox9
ﬂ  ox/ﬂ  ox-vil-
Cre mice
In addition to the general mild hyperplasia found throughout the 
intestine of Sox9
fl  ox/fl  ox-vil-Cre mice, extensive hyperplasia oc-
curred, with occasional glandulocystic features, in the distal half 
of Sox9
fl  ox/fl  ox-vil-Cre mice colon. Numerous crypts were en-
larged and branched, and some were extensively dilated with a 
cystic appearance (Fig. 6, a and b). Proliferation was correctly 
restricted to the bottom of hyperplastic crypts (Fig. 6 c). Cells 
constituting cystic crypts also proliferated, albeit modestly (Fig. 
6 d), and were poorly differentiated (Fig. S2, D–F). In addition, 
tubulovillous microadenomas occasionally developed in hyper-
plastic areas of the epithelium with atypical tissue architecture 
(Fig. 6 e). Crypts with dysplastic features, including poor differ-
entiation, pseudostratifi  ed nuclei, multiadenoid structures, and 
numerous mitosis, spontaneously developed in several locations 
along the colon of Sox9-defi  cient mice (Fig. 6 f). Interestingly, 
slight crypt hyperplasia/dysplasia was also detectable in the 
  colon of 3-wk-old Sox9-defi  cient mice, indicating that these 
  defects appear early but become more severe with time, likely as 
a consequence of increased cell proliferation (Fig. S2, G–J).
Some Sox9
fl  ox/fl  ox-vil-Cre mice had no detectable lesions 
but also had a normal colon morphology and had Paneth cells 
in their small intestine (unpublished data). In such mice, Sox9 
staining was invariably identical to that of wild-type mice 
  (unpublished data), indicating ineffi  ciency of the Cre recombinase. 
Thus, dysplastic-like lesions were always found in the colon of 
true Sox9-defi  cient mice. That we never observed true carcinoma 
in the intestine of Sox9-defi  cient mice up to 6 mo old suggests, 
in turn, that Sox9 defi  ciency may not be suffi  cient, per se, to 
  induce cell transformation.
Hyperplastic- and dysplastic-like crypts were found to 
strongly overexpress Wnt pathway–related genes, such as 
c-Myc and cyclin D1, suggesting an increase of Wnt-dependent 
transcriptional activity (Fig. 6, compare g with h, and i with j). 
This overexpression resulted from both an increase in the num-
ber of c-Myc– and cyclin D1–expressing cells and increased 
staining intensities in individual positive cells (unpublished 
data). Expression of the Ki-67 proliferation marker was also af-
fected (Fig. 6, compare k with l). This fi  nding was confi  rmed by 
Western blot analysis of extracts from Sox9
fl  ox/fl  ox and Sox9
fl  ox/fl  ox-
vil-Cre mice. Although few variations were found in the small 
intestine, likely because the few proliferating crypt cells are not 
suffi  ciently represented in the whole epithelial cell population, 
a clear increase of c-Myc and cyclin D1 was evident in the 
Sox9-defi  cient colon (Fig. 6 m). The increase in cell proliferation 
rate in Sox9-defi  cient mice (estimated as 15% from BrdU incorpor-
ation rates) was probably not suffi  cient to be clearly visualized 
with an anti-PCNA Western blot (Fig. 6 m). An alternative 
explanation is that, although crypt hyperplasia and increased 
BrdU intake are evident, the density of crypts is reduced in 
Sox9-defi  cient animals, which may compensate the increased 
proliferation observed in each crypt. That the overexpression of 
Wnt target genes is much more visible in the colon samples may 
Figure 7.  Sox9 ﬁ   ne-tunes the activity of the 
𝗃-catenin–Tcf4 transcriptional effector of the Wnt 
signaling pathway. (a and b) No alteration of the 
number of cells containing nuclear β-catenin (arrows) 
is found in Sox9-deﬁ  cient animals. Bars, 40 μm. 
(c and d) Analysis of the transcriptional activity 
of the β-catenin–Tcf4 complex, using a luciferase 
reporter system (Morin et al., 1997). Endogenous 
transcriptional activity of the β-catenin–Tcf4 com-
plex. Transient overexpression of Sox9 inhibits the 
β-catenin–Tcf4 activity, whereas overexpressing 
∆CSox9 increases it (c). Similarily, induction of 
Sox9 overexpression in the HT29-16E-Sox9 cell 
line causes inhibition of β-catenin–Tcf4 transcrip-
tional activity, whereas inducing overexpression of 
∆CSox9 in the HT29-16E-∆CSox9 cell line resulted 
in a considerable increase of this activity (d). Regu-
lation of the β-catenin–Tcf4 transcriptional activity 
impacted c-Myc and cyclin D1 mRNA expression. 
The amounts of mRNA after doxycycline induction 
are indicated as a percentage of the noninduced 
state (e, dashed line). These variations at the mRNA 
level were reﬂ  ected at the protein level (f).JCB • VOLUME 178 • NUMBER 4 • 2007  642
refl  ect either the bigger size of the crypts relative to the entire 
epithelium in the colon compared with the small intestine or the 
presence of dysplastic-like lesions, which strongly overexpress 
Wnt target genes, in the colon samples.
We then asked whether these alterations in the small in-
testine and colon structure may impact the mouse physiology. 
Indeed, the weight of Sox9
fl  ox/fl  ox-vil-Cre animals was always 
reduced (unpublished data), compared with the related Sox9
fl  ox/fl  ox 
control mouse. This reduction was modest (mean 17%; n = 10) 
but, despite the heterogeneity in the age and sex of the pairs of 
animals tested, reached statistical signifi  cance (P < 0.05, t test). 
In addition, stools from Sox9
fl  ox/fl  ox-vil-Cre mice were more 
  hydrated than those of control mice, indicating a partial im-
pairment of the colonic epithelium function in Sox9-defi  cient 
animals (Fig. 6 n).
Sox9 modulates Wnt pathway 
activity in vitro
To understand the molecular bases of the observed up-regulation 
of Wnt target genes, we compared the expression of nuclear 
β-catenin, the hallmark of Wnt signaling, in Sox9-defi  cient versus 
control mice. Comparable results were found in both situations, 
with a typical nuclear staining of some cells scattered through 
the crypt bottom (Fig. 7, a and b; and Fig. S3, A and B, available 
at http://www.jcb.org/cgi/content/full/jcb.200704152/DC1), 
indicating that the overexpression of Wnt target genes found 
in Sox9-defi  cient animals was not due to increased levels of 
β-catenin, in the crypt nuclei of Sox9
fl  ox/fl  ox-vil-Cre mice.
We and others have shown that the level of Sox9 ex-
pression regulates the transcriptional activity of the β-catenin–
Tcf4 complex in cultured HEK293 cells (Akiyama et al., 2004b; 
Blache et al., 2004). Physical interaction between Sox9 and 
β-catenin has been reported, resulting in a competition between 
Sox9 and Tcf4 for binding to β-catenin. Formation of the Sox9–
β-catenin complex results in degradation of the two proteins 
(Akiyama et al., 2004b). We thus hypothesized that the absence 
of Sox9 in crypt cells of Sox9
fl  ox/fl  ox-vil-Cre mice, where Wnt 
signaling is physiologically active, might result in increased 
availability of the nuclear pool of β-catenin for binding to Tcf4. 
To test this, we analyzed the transcriptional activity of the 
β-catenin–Tcf4 complex after manipulation of Sox9 expression 
in colon carcinoma cell lines containing a constitutive activation 
of the β-catenin–Tcf transcriptional complex (Korinek et al., 
1997). The basal β-catenin–Tcf4 activity present in DLD-1 
cells was effi  ciently inhibited by Sox9 and increased after over-
expression of a dominant-negative version of Sox9 (Fig. 7 c). 
Comparable results were obtained in other colon carcinoma cell 
lines, such as SW480, HCT116, and HT29Cl.16E (Fig. S3, C–E), 
demonstrating that even in colon carcinoma cells, in which 
 nuclear  β-catenin accumulates constitutively, the level of Sox9 
  expression critically modulates the level of β-catenin–Tcf tran-
scriptional activity.
We used the HT29Cl.16E-Sox9 and HT29Cl.16E-∆CSox9 
cell lines, inducibly overexpressing full-length or C-terminally 
truncated Sox9, respectively, to test whether Sox9 overexpres-
sion would result in a down-regulation of expression of endog-
enous Wnt pathway target genes. Doxycycline induction of Sox9 
or ∆CSox9 expression also resulted in down- or up-regulation, 
respectively, of the β-catenin–Tcf complex activity (Fig. 7 d). 
Using real-time PCR, we found that induction of Sox9 ex-
pression resulted in a down- regulation of c-Myc and cyclin D1 
mRNA expression, whereas that of ∆CSox9 resulted in an up-
regulation of these two Wnt target genes (Fig. 7 e). C-Myc and 
cyclin D1 protein expression changed accordingly (Fig. 7 f). 
Figure 8.  Sox9 transcriptionally activates expression of inhibitors of the 
𝗃-catenin–Tcf activity. Structure–function analysis of the inhibitory function 
of Sox9 on the β-catenin–Tcf activity (a–e) in DLD-1 cells. (a) Diagram 
showing the different constructs used in this study. (b) Transcriptional activ-
ity of Sox9 and its mutated or truncated versions on a Sox-luciferase 
  reporter system. (c) Inhibition of the β-catenin–Tcf activity by Sox9 and its 
truncated or mutated versions. (d) Transcriptional activity of the Sox9-
VP16 chimeric protein compared with that of Sox9 on a Sox-luciferase re-
porter system. (e) Inhibition of the β-catenin–Tcf activity by Sox9 and 
Sox9-VP16. In panels b and d, the activity of the wild-type Sox9 construct 
is arbitrarily set to 100. In panels c and e, the endogenous β-catenin–Tcf 
activity is arbitrarily set to 100. (f and g) Real-time RT-PCR analysis of the 
expression of the inhibitor of β-catenin and Tcf (ICAT) and Groucho-related 
inhibitors of the β-catenin–Tcf activity in HT29Cl.16E-Sox9 cells before 
and after induction of exogenous Sox9 expression (f) and in the intestinal 
mucosa of Sox9
ﬂ  ox/ﬂ  ox versus Sox9
ﬂ  ox/ﬂ  ox-vil-Cre mice (g). Results are ex-
pressed relative to the noninduced or nonrecombined states. Standard 
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This result demonstrates modulation of expression of key 
β-catenin–Tcf target genes by Sox9, but the molecular mecha-
nism underlying this regulation remained unclear, as the ∆C-Sox9 
construct does not contain the domain thought to interact with 
β-catenin (Akiyama et al., 2004b).
The previously reported physical interaction between 
Sox9 and β-catenin had been detected after overexpression of 
tagged Sox9 and β-catenin in COS cells (Akiyama et al., 2004b). 
We reasoned that if this interaction was important to modulate 
Wnt signaling in colon carcinoma cells, then the endogenous 
complex should be readily detectable in these cells. Despite 
repeated efforts, no β-catenin–Sox9 complex could be immuno-
precipitated, although Tcf4 coimmunoprecipitated with β-catenin 
(unpublished data). We concluded that β-catenin–Sox9 com-
plexes are probably not abundant in colon carcinoma cells. In 
addition, the subcellular localization of both β-catenin and Tcf4 
was unchanged after transient overexpression of Sox9 in SW480 
cells (Fig. S4, A–F, available at http://www.jcb.org/cgi/content/
full/jcb.200704152/DC1), and the level of β-catenin expression 
was not decreased after induction of Sox9 expression in the 
HT29Cl.16E-Sox9 cells (Fig. S4 G).
To identify another possible mechanism, we performed 
mutational analysis of the Sox9-mediated inhibition of the 
β-catenin–Tcf activity. The W143R point mutation (Fig. 8 a) was 
originally identifi  ed in a campomelic dysplasia patient and abol-
ishes the DNA binding properties of Sox9 (Meyer et al., 1997). 
We introduced this mutation in both the Sox9 and ∆CSox9 con-
structs. The resulting products did not have any transcriptional 
activity using Sox-luciferase reporters (Fig. 8 b) and failed to 
modify β-catenin–Tcf activity (Fig. 8 c). This indicates that 
Sox9-mediated inhibition of the β-catenin–Tcf activity requires 
an intact DNA binding domain of Sox9, which raises the possi-
bility that this inhibition might be at least partly due to transcrip-
tional regulation. To test this, we used a Sox9 construct in which 
the C-terminal domain of Sox9, involved in transactivation, and 
in the interaction with β-catenin (Akiyama et al., 2004b), is 
  removed and replaced by the unrelated VP16 transactivating 
  domain (Kamachi et al., 1999; Fig. 8 a). Transient transfection 
of this construct in colon carcinoma cells showed that the Sox9-
VP16 chimeric protein potently activates transcription of a Sox-
luciferase reporter gene (Fig. 8 d) and inhibits the β-catenin–Tcf 
activity even more effi  ciently than wild-type Sox9 (Fig. 8 e). We 
conclude that Sox9-mediated inhibition of β-catenin–Tcf activ-
ity involves transcriptional regulation.
We then aimed to identify potential Wnt pathway inhibi-
tors, such as the inhibitor of β-catenin and Tcf (ICAT; Tago 
et al., 2000) and Groucho-related (Grg/TLE) corepressors (Cavallo 
et al., 1998; Roose et al., 1998), which might be transcriptionally 
regulated by Sox9. In vitro, the induction of Sox9 expression in 
HT29Cl.16E-Sox9 cells resulted in increased expression of the 
ICAT and TLE2-4 genes, whereas the expression of TLE1 was 
unaffected (Fig. 8 f). We then analyzed the expression of the 
mouse homologues of these genes in Sox9
fl  ox/fl  ox-vil-Cre mice 
and Sox9
fl  ox/fl  ox mice, and we found that, again, the expression of 
Grg2, -3, and -4 was obviously down-regulated in Sox9-defi  cient 
mice, whereas that of Grg1 remained unchanged (Fig. 8 g). Icat 
expression seemed unchanged in Sox9-defi  cient mice, but this 
result varied with the samples analyzed (unpublished data). 
Although additional Wnt pathway inhibitors may be involved, 
this result provides a basis to explain the increased expression of 
Wnt target genes observed in Sox9-defi  cient mice, despite the 
absence of an increase in nuclear β-catenin expression.
Sox9 expression deﬁ  nes 
compartmentalization of the crypt
When we stained small intestinal tissue for c-Myc and cyclin 
D1 protein expression, we found that both genes were expressed 
as expected in the stem/progenitor cell compartment but that 
their expression was strongly decreased in Paneth cells (Fig. 9, 
a and c). In contrast, the absence of Sox9 resulted in uniform 
expression of both c-Myc and cyclin D1 in the whole crypt bottom 
(Fig. 9, b and d), which then lacked Paneth cells.
Thus, Sox9 expression may defi  ne a compartment in which 
nuclear β-catenin expression results in a genetic program that 
includes low c-Myc and cyclin D1 expression, and in which 
differentiation of Paneth cells occurs. In the absence of Sox9, 
Paneth cells do not develop, and the genetic program characterized 
by high c-Myc and cyclin D1 expression expands to include the 
whole crypt base.
Discussion
This study shows that loss of Sox9 function affects the intestinal 
epithelium physiopathology at the level of (1) cell differentia-
tion, (2) tissue homeostasis, and (3) colon tissue morphology. 
These different aspects of the phenotype were sex independent.
Figure 9.  Alteration of c-Myc and cyclin D1 expression in the bottom of 
Sox9-deﬁ  cient crypts. C-Myc and cyclin D1 expression was analyzed by 
immunohistochemistry in the intestine of Sox9
ﬂ  ox/ﬂ  ox (a and c) and Sox9
ﬂ  ox/ﬂ  ox-
vil-Cre (b and d) mice. Arrows indicate the Paneth cell compartment in 
Sox9
flox/flox control mice (a and c) and the equivalent location in the 
Sox9
ﬂ  ox/ﬂ  ox-vil-Cre mice (b and d). Bars, 50 μm.JCB • VOLUME 178 • NUMBER 4 • 2007  644
Control of cell differentiation by Sox9—
relationship with the Wnt pathway
Interference with the Wnt pathway results in depletion of the 
Paneth cell lineage (Pinto et al., 2003) and, conversely, loss of 
the key negative regulator of the pathway, Apc, results in an ex-
pansion of the Paneth cell lineage (Sansom et al., 2004; Andreu 
et al., 2005). In addition, the terminal maturation of Paneth cells 
requires Wnt signaling through the Frizzled-5 receptor (van Es 
et al., 2005). As we previously showed that Sox9 is a transcrip-
tional target of Wnt signaling, the Sox9 requirement for the dif-
ferentiation of the Paneth cell lineage is likely to refl  ect its role 
to specify this specifi  c aspect of the Wnt pathway. In this view, 
Sox9 function would be expected to occur at an earlier stage 
than the Wnt–Frizzled-5 pathway, during the course of Paneth 
cell differentiation, as this pathway was previously shown to be 
involved in the terminal differentiation of already committed 
Paneth cells (van Es et al., 2005). Although less likely, an alter-
native in which Sox9 and Wnt signaling, as two distinct path-
ways, would control Paneth cell differentiation cannot be 
formally excluded.
The functional consequence of the loss of the Paneth cell 
lineage, a component of the innate immunity, is still a matter of 
debate. In this study, we did not fi  nd an increased mortality 
in the Sox9-defi  cient mice lacking Paneth cells. In agreement 
with this, a previous experiment with ablation of Paneth cells 
concluded that the turnover of epithelial cells was not grossly 
perturbed. In addition, no major alteration of microorganism 
population along the crypt–villus axis was detected (Garabedian 
et al., 1997). On the other hand, a role of Paneth cells in regulat-
ing the villus angiogenesis (Stappenbeck et al., 2002) and in 
clearing bacterial infections (Wilson et al., 1999) have been de-
scribed, although no major impact was reported at the physio-
pathological level.
The reduction of goblet cell numbers indicates that Sox9 
is also involved in the differentiation of this lineage. This quan-
titative impact of the Sox9 defi  ciency on the goblet cell popula-
tion is probably physiologically relevant given the key role of 
mucus in protecting the epithelium against the luminal content, 
well illustrated, for instance, by the colon epithelium tumori-
genesis resulting from a deletion of the Muc2 gene (Velcich 
et al., 2002). This function of Sox9 in regulating the differentia-
tion of goblet cells might also play a part in the cellular response 
to Wnt signals, as altered goblet cell differentiation was also 
found in mice in which the Wnt pathway has been impaired 
(Pinto et al., 2003). That Sox9 defi  ciency results in the complete 
absence of Paneth cells but leads only to a reduction of the gob-
let cell lineage might indicate different Sox9 requirements for 
the differentiation of these two lineages, and suggests that addi-
tional factors might be involved in this process, at least for gob-
let cell lineage differentiation.
What is the function of Sox9 in goblet 
cell differentiation?
In a previous report, we showed that overexpression of Sox9 in 
the LS174T colon carcinoma cell line repressed the Muc2 gene 
(Blache et al., 2004). This apparently contrasts with the present 
fi  nding that the absence of Sox9 in the intestinal epithelium 
causes an obvious reduction of the number of goblet cells 
in vivo. The remaining goblet cells express the Muc2 gene, which 
indicates their maturation into functional mucus-producing 
cells. The apparent discrepancy between the two experiments 
likely lies in the fundamentally different nature of the experi-
mental models used (i.e., LS174T human colon carcinoma cells 
grown in vitro versus mouse intestinal epithelium in its physio-
logical tissue context). We conclude that Sox9 defi  nitely plays a 
role in the differentiation of the goblet cell lineage, and we hy-
pothesize that this role occurs primarily at the level of cell fate 
choice, similar to what was shown previously in the developing 
nervous system (Spokony et al., 2002). In addition, as suggested 
by in vitro data and the respective expression patterns of Sox9 
and Muc2, down-regulation of Sox9 expression might be neces-
sary to allow terminal maturation of committed goblet cells, al-
though this hypothesis is diffi  cult to test using the present gene 
inactivation model.
“Gatekeeper” role of Sox9 in modulating 
Wnt pathway activity?
Our in vitro and in vivo results indicate that Sox9 down-regulates 
the transcriptional activity of the β-catenin–Tcf4 complex 
on endogenous target promoters, such as the c-Myc and cyclin D1 
gene promoters. Although previous studies indicated that Sox9 
could inhibit the activity of the β-catenin–Tcf4 complex in 
HEK293 cells transiently transfected with artifi  cial luciferase 
reporters (Akiyama et al., 2004b; Blache et al., 2004), the ob-
served regulation of the β-catenin–Tcf4 complex transcriptional 
activity on endogenous target gene promoters, in cultured colon 
carcinoma cells known to have a constitutive β-catenin–Tcf4 
activity, was somewhat unexpected. In this study, although 
down-regulation of an artifi  cial luciferase Tcf reporter gene was 
obvious, that of endogenous β-catenin–Tcf target genes was 
slighter and necessitated optimization of the cell culture condition. 
Indeed, Sox9-mediated down-regulation c-Myc and cyclin D1, 
which was hardly detectable in low-confl  uence cell culture 
condition, became evident when a more confl  uent cell culture 
setting was used. In agreement with this, a down-regulation of 
the β-catenin–Tcf4 complex has been reported as cultured 
colon carcinoma cells reach confl  uence (Mariadason et al., 2001). 
Thus, in low- confl  uence culture conditions, the endogenous 
level of β-catenin–Tcf4 complex likely saturates the endog-
enous target gene promoters, even in the presence of exogenous 
Sox9. In contrast, the transfected luciferase Tcf reporter system 
exists in multiple copies in each transfected cell, which might 
explain its increased sensitivity to Sox9 regulation. When cells 
are more confl   uent, the endogenous β-catenin–Tcf activity 
likely decreases and allows regulation of endogenous Wnt tar-
get genes by Sox9. This also explains the apparent discrepancy 
between the results presented here and in our previous report, in 
which we showed that c-Myc was not regulated by Sox9 in low-
confl  uence cell culture conditions (Blache et al., 2004). Thus, 
even in cells in which the Wnt pathway is constitutively active, 
Sox9 may play an important retroinhibition role.
We could show that the transcriptional activity of Sox9 is 
involved in this inhibition, and genes encoding inhibitors of the 
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in vitro and in vivo. This fi  nding might explain how many Sox 
proteins, which lack homology outside the HMG DNA binding 
domain, have the conserved property of inhibiting β-catenin–
Tcf activity.
In vivo, inactivation of the Sox9 gene results in an increase 
in the rate of BrdU incorporation in crypt epithelial cells. This 
correlates with the development of hyperplastic- and dysplastic-
like crypts, which overexpress Wnt target genes. The percent-
age of BrdU-positive cells obtained in this study with the 
Sox9
fl  ox/fl  ox control mice (46–56% with a 2-h BrdU pulse) is 
consistent with previous analyses showing a 
3H labeling index 
of 29–33% after a 1-h treatment with 
3H-thymidine (Cheng and 
Bjerknes, 1982). The 16–32% increase in BrdU-positive cells 
in Sox9
flox/flox-vil-Cre mice is therefore likely to signifi  cantly 
impact epithelial homeostasis, given the rate of renewal of the 
intestinal epithelium. This increased proliferation rate likely 
explains the occurrence of Wnt target genes overexpressing 
hyperplastic- and dysplastic-like crypts in Sox9-defi  cient mice, 
whereas this was never observed in Sox9
fl  ox/fl  ox animals. In 
agreement with this, an apparent increase of Musashi-expressing 
cells was found in Sox9-defi  cient mice, suggesting that Sox9 might 
regulate the number of stem cells in the intestinal epithelium.
A role of Sox9 in regulating cell proliferation has already 
been proposed in chondrocytic cell lines, in which Sox9 pro-
moted differentiation (Panda et al., 2001), as well as in breast and 
prostate tumor cell lines (Afonja et al., 2002; Drivdahl et al., 
2004). Here, however, Sox9 is specifi  cally expressed, in a normal 
physiological situation, in the proliferative compartment of the 
intestinal epithelium, and activity of the protooncogenic Wnt path-
way is required for its expression (Blache et al., 2004). Thus, 
Sox9 might function as a gatekeeper in intestinal crypts to pre-
vent overactivity of the Wnt-dependent transcriptional program.
Role of the Sox9-mediated inhibition 
of the Wnt pathway in the differentiation 
of Paneth cells
Wnt signaling is known to be important for the maintenance of 
the proliferating compartment (Korinek et al., 1998; Pinto et al., 
2003; Kuhnert et al., 2004), as well as for the differentiation and 
maturation of Paneth cells (Pinto et al., 2003; Andreu et al., 
2005; van Es et al., 2005). Here, we found that c-Myc, a central 
effector of the Wnt pathway, as well as cyclin D1, was expressed 
in the proliferative compartment of the small intestinal epithe-
lium but not, or at a much lower level, in the Paneth cell com-
partment of wild-type mice. This was unexpected given that 
Paneth cells have been reported to express the highest levels of 
nuclear β-catenin (van Es et al., 2005). This suggests that dis-
tinct genetic programs are set, downstream to the Wnt pathway, 
in the stem/progenitor versus Paneth cell compartments, and 
this was refl  ected by a recent transcriptomic study (Van der 
Flier et al., 2007). The absence of Sox9 results in a single pro-
liferative stem/progenitor compartment, in which all the cells 
express c-Myc and cyclin D1. This suggests that Sox9 is re-
quired to specify the Paneth cell compartment, in which the 
presence of nuclear β-catenin results in a “Paneth cell” genetic 
program instead of a “stem/progenitor” program that includes 
c-Myc expression.
This also raises the question of the role of Sox9 in Wnt 
pathway–triggered tumorigenesis. Our data suggest that loss of 
Sox9 might promote tumorigenesis, either through the reduction 
of mucus protection or through up-regulation of the β-catenin–
Tcf activity. It should be noted, however, that up-regulation of 
the β-catenin–Tcf complex activity by loss of Sox9 function is 
expected to occur only in cells in which Wnt pathway activity 
preexists, and Sox9 deletion might not be suffi  cient to cause 
neoplasia. Consistent with this, no evidence for spontaneous neo-
plasms was found in Sox9-defi  cient mice up to 6 mo old.
Conclusion
This study reveals the dual role played by Sox9 in relation with the 
Wnt pathway. (1) It likely mediates part of the Wnt-dependent 
program, involved in Paneth and goblet cell differentiation. 
Sox9 thus provides the fi  rst example of a transcription factor in-
volved in specifying the cellular response to Wnt signals, which 
potentially trigger very diverse cellular behaviors, including 
proliferation, differentiation, sorting of the cells along the 
crypt–villus axis, etc. (2) Sox9 fi  ne-tunes the transcriptional out-
put of the canonical Wnt pathway in vitro, and inactivation of 
this gene causes an increase of BrdU incorporation rate and 
leads to hyperplasia and dysplasia of the intestinal epithelium 
and increased putative stem cell numbers. (3) Finally, Sox9 may 
also act independently of the Wnt pathway to control colon 
  epithelium morphology, a role that had not been previously re-
ported for the Wnt pathway, although architectural degeneration 
was described after Dickkopf-1 overexpression in the colon epi-
thelium (Kuhnert et al., 2004).
Materials and methods
Mouse lines
The vil-Cre strain (el Marjou et al., 2004) was in a nearly pure C57BL/6 
background (at least 14 backcrosses to this background). To generate 
Sox9
+/ﬂ  ox mice (Kist et al., 2002), exons 2 and 3 of the Sox9 gene were 
ﬂ  anked by LoxP sequences. Cre recombination results in the deletion of 
the last two exons, which encode part of the HMG DNA binding domain 
and the transactivation domain, thus resulting in a likely null allele. A pep-
tide might still be produced from the ﬁ  rst exon, but this would not contain 
any known functional domain. Sox9
+/ﬂ  ox mice were originally on a 
129P2/OlaHsd × C57BL/6 mixed genetic background and have been 
backcrossed to C57BL/6 for three generations. These N3 mice were 
made Sox9
ﬂ  ox/ﬂ  ox by sister–brother mating before being crossed with the 
vil-Cre strain.
Cells and cell culture conditions
Colorectal cancer cell lines HCT116, HT29.16E, DLD1, and SW480 were 
cultured at 37°C in Dulbecco’s modiﬁ   ed Eagle’s medium supplemented 
with 10% fetal bovine serum (Eurobio), 1% L-glutamine, and penicillin/
streptomycin. The HT29.16E-Sox9 and HT29.16E∆CSox9 cell lines were 
described previously (Blache et al., 2004; Jay et al., 2005).
DNA constructs, transient transfections, and luciferase assays
Full-length human Sox9 and C-terminally truncated (dominant-negative) 
  human Sox9 constructs were described previously (Südbeck et al., 1996), 
as were the pTOP-FLASH and pFOP-FLASH reporter constructs (Morin 
et al., 1997). The Sox9-VP16 construct (Kamachi et al., 1999) was a gift 
from H. Kondoh (Institute for Molecular and Cell Biology, Osaka University, 
Osaka, Japan). The full-length human Sox9 (W143R) and the C-terminally 
truncated human Sox9 (W143R) expression constructs were constructed 
from a human Sox9(1–304) construct containing the W143R mutation, 
provided by P. de Santa Barbara (Institut National de la Santé et de la 
  Recherche Médicale, Montpellier, France). DLD1, SW480, HCT116, and 
HT29-16E cells were cotransfected (EXGEN500; Euromedex) with 0.25 μg JCB • VOLUME 178 • NUMBER 4 • 2007  646
pcDNA3, Sox9, or ∆CSox9 DNA constructs and 0.25 μg TCF/LEF-1 re-
porter (pTOP-FLASH) or control vector (pFOP-FLASH), using standard 
procedures. 0.025 μg pRLSV-Renilla was used as an internal control. 
Luciferase assays were performed with the Dual luciferase reporter assay 
system (Promega) according to the manufacturer’s instructions. Luciferase 
activities in cell lysates were normalized relative to the Renilla luciferase 
activity, and the indicated activities represent the TOPFLASH/FOPFLASH 
ratio, indicative of the Tcf binding site-speciﬁ  c activity. Each experiment 
was performed in duplicate and repeated several times, and representa-
tive examples are shown.
Quantitative RT-PCR
Total RNAs were prepared using the RNeasy minikit (QIAGEN) from 
HT29.16E-Sox9 or HT29.16E-∆CSox9 cells grown to 100% conﬂ  uence 
and treated or not for 6 d with doxycycline. For mRNA quantiﬁ  cation, 2.5 μg 
of total RNA was pretreated with DNase RQ1 (Promega) for 30 min at 
37°C and used for reverse transcription with M-MLV reverse transcriptase 
(Invitrogen). Quantitative PCR was performed using the LightCycler FastStart 
DNA MasterPlus SYBR Green I kit (Roche Diagnostics). Results were nor-
malized with GAPDH expression.
Primers used are as follows: hGAPDH, forward (5′-G  G  T  G  G  T  C  T  C  C  T-
C  T  G  A  C  T  T  C  A  A  C  A  -3′) and reverse (5′-G  T  T  G  C  T  G  T  A  G  C  A  A  A  T  T  C  G  T  T  G  T  -3′); 
hCYCLIN D1, forward (5′-C  C  G  T  C  C  A  T  G  G  G  G  A  A  G  A  T  C  -3′) and reverse 
(R-5′-A  T  G  G  C  C  A  G  C  G  G  G  A  A  G  A  C  -3′); hc-MYC, forward (5′-C  G  T  C  T  C  C  A-
C  A  C  A  C  A  T  C  A  G  A  G  C  A  A  -3′) and reverse (5′-T  C  T  T  G  G  C  A  G  C  A  G  G  A  T  A  G  T  C-
C  T  T  -3′); hICAT, forward (5′-G  C  T  C  T  G  G  T  G  C  T  T  T  A  G  T  T  A  G  G  -3′) and reverse 
(5′-G  C  A  C  T  T  G  G  T  T  T  C  T  T  T  C  T  T  T  T  C  -3′); hTLE1, forward (5′-A  A  A  G  A  G  G  A  G  G-
C  G  A  C  A  A  G  T  -3′) and reverse (5′-T  T  C  C  G  T  T  C  C  T  C  A  A  T  C  C  T  A  C  A  A  -3′); hTLE2, 
forward (5′-G  C  C  C  T  G  C  C  T  A  G  G  A  A  C  C  G  T  -3′) and reverse (R-5′-T  T  T  T  A  T  T  T-
C      C  A  C  G  A  G  G  T  C  C  C  C  -3′); hTLE3, forward (5′-C  T  C  C  C  T  C  A  A  G  T  T  C  G  C  C  T A  C  -3′) 
and reverse (5′-T  C  C  G  C  T  G  A  A  A  T  G  T  C  A  C  A  A  C  T  C  -3′); hTLE4, forward 
(5′-T  G  T  G  G  C  A  A  A  T  G  G  T  T  T  G  T  A  A  G  C  A  C  -3′) and reverse (5′-C  C  C  C  A  G  A  G  C-
C  A  G  T  G  A  C  A  A  T  G  T  A  T  -3′); hLYSOZYME, forward (5′-A  A  A  C  C  C  C  A  G  G  A  G  C-
A  G  T  T  A  A  T  -3′) and reverse (5′-C  A  A  C  C  C  T  C  T  T  T  G  C  A  C  A  A  G  C  T  -3′); hMMP7, 
forward (5′-G  A  C  T  T  A  C  C  G  C  A  T  A  T  T  A  C  A  G  T  G  -3′) and reverse (5′-A  T  C  C  C  T  A-
G  A  C  T  G  C  T  A  C  C  -3′); hANG4, forward (5′-C  T  G  G  G  C  G  T  T  T  T  G  T  T  G  G  T  C  -3′) 
and reverse (5′-G  G  T  T  T  G  G  C  A  T  C  A  T  A  G  T  G  C  T  G  G  -3′); mGapdh, forward 
(5′-A  T  T  G  T  C  Z  G  C  A  A  T  G  C  A  T  C  C  T  G  -3′) and reverse (5′-A  T  G  G  A  C  T  G  T  G  G  T  C-
A  T  G  A  G  C  C  -3′); mIcat, forward (F-5′-C  C  C  G  G  G  A  A  G  A  G  T  C  C  G  G  A  G  G  -3′) 
and reverse (5′-G  T  C  T  T  C  C  G  T  C  T  C  C  G  A  T  C  T  G  G  -3′); mGrg1, forward (5′-G  C  T      -
G  T  G  G  T  G  G  C  C  T  A  T  G  G  G  -3′) and reverse (5′-C  A  T  T  T  G  G  C  C  A  T  C  A  G  C  A  G  T  A  A-
C  A  T  -3′); mGrg2, forward (5′-G  A  G  C  T  G  G  A  T  C  A  G  G  G  A  T  T  T  A  C  A  C  T  -3′) and 
reverse (5′-C  C  A  G  C  C  T  G  G  T  T  T  A  C  A  T  A  G  T  T  T  C  A  -3′); mGrg3, forward (5′-C  T  G    -
T  G  A  C  A  T  T  T  C  A  G  C  G  G  A  T  G  A  C  A  -3′) and reverse (5′-C  C  C  T  C  C  T  T  C  T  G  C  C  G  T-
C  C  T  -3′); mGrg4, forward (5′-G  C  T  G  C  A  G  C  G  A  C  G  G  T  A  A  C  A  T  C  -3′) and 
reverse (5′-C  A  G  A  G  C  T  T  G  G  T  G  C  C  A  T  C  A  T  T  A  G  A  -3′).
Immunohistochemistry and Western blot
Immunohistochemistry was performed essentially as described previously 
(Blache et al., 2004). Sections of human intestinal metaplasia were pro-
vided by F. Bibeau (CRLC Val d’Aurelle Lamarque, Montpellier, France). In 
brief, for preparation of mouse intestinal sections, the intestinal tract was 
dissected as a whole from 2–6-mo-old mice and ﬂ  ushed gently with cold 
PBS to remove any fecal content. The small intestine and colon were rolled 
up into a compact circle and ﬁ  xed in 4% PFA in PBS at RT for 4 h, dehy-
drated, embedded in parafﬁ  n, and sectioned at 5 μm, using standard pro-
cedures. Sections were dewaxed in a xylene bath and rehydrated in 
graded alcohols. Endogenous peroxidase activity was quenched with 
1.5% H2O2 in methanol for 20 min and washed in PBS. Antigen retrieval 
was performed by boiling slides in 10 mM sodium citrate buffer, pH 6.0, 
except for anti–c-Myc and anti–cleaved Caspase3 antibodies, for which 
antigen retrieval was performed by boiling slides 20 min in 100 mM TRIS 
and 12.6 mM EDTA, pH 9.0. Nonspeciﬁ  c binding sites were blocked with 
1% BSA, 3% NGS, and 0.2% Triton X-100 in PBS for 45 min at RT for all 
antibodies staining except for anti–c-Myc (1% BSA in PBS) and anti-Ki67 
(no blocking). Slides were incubated with the primary antibodies overnight 
at 4°C in PBS with 0.1% BSA. In all cases, Envision+ (DakoCytomation) 
was used as a secondary reagent, stainings were developed with DAB 
(brown precipitate) or Vector Vip substrate (purple precipitate), and hema-
toxylin counterstain was used. After dehydration, sections were mounted in 
Pertex (Histolab). For alkaline phosphatase activity staining, sections were 
dewaxed and rehydrated as described, and the alkaline phosphatase sub-
strate (Vector red; Vector Laboratories) was applied for 10 min. Sections 
were counterstained, dehydrated, and mounted as described. For BrdU 
countings, mice were injected with a solution (0.1 milligram per gram of mouse 
body weight) of Brdu diluted in PBS. Mice were killed 2 h after injection. 
For BrdU staining, the same method as explained above was used, except 
for an additional step in HCl 2N for 45 min, added after antigen retrieval. 
For the Musashi staining, an ABC kit (Vectastain) was used instead of the 
Envision+ system.
For Western blotting, an equal amount of protein, measured by the 
Bradford assay, was loaded on each lane of the gel. Protein lysates and 
immunoblotting were performed as described previously (Hollande et al., 
2003). Proteins were visualized using ECL Plus (GE Healthcare), and the 
bands were quantiﬁ  ed by densitometry using ImageJ 1.32J (NIH).
Quantiﬁ  cation of c-Myc and cyclin D1 stainings
Immunoﬂ  uorescence stainings were performed essentially as immunohisto-
chemical stainings, but a goat anti–rabbit secondary antibody (Alexa Fluor 
488; Invitrogen) was used, and nuclei were counterstained with Hoechst. 
Fluorescence quantiﬁ  cations were performed with ImageJ software. Nuclei 
were selected using the freehand selection tool, and integrated densities 
were measured.
Antibodies
The Muc2 antibody (1:250) was provided by I. Van Seuningen (Institut 
  National de la Santé et de la Recherche Médicale, Lille, France), the Cdx2 
antibody (1:200) was provided by J.-N. Freund (Institut National de la 
Santé et de la Recherche Médicale, Strasbourg, France), the Musashi-biotin 
antibody (1:500) was provided by H. Okano (Keio University, Tokyo, Japan), 
and the anti-Sox9 was described previously (de Santa Barbara et al., 
1998). β-Actin A5441 (Western blot; 1:5,000) was purchased from Sigma-
Aldrich, anti-Ki-67 (1:200) and anti-lysozyme (1:1,000) were purchased 
from DakoCytomation, anti-PCNA (1:100) and anti–cyclin D1 (1:100) 
were purchased from Neomarker, anti-c-Myc (1:50) was purchased from 
Santa Cruz Biotechnology, Inc., anti–E-cadherin (1:150) and anti–β-catenin 
(1:50) were purchased from BD Biosciences, anti-Claudin2 (1:100) was 
obtained from Zymed Laboratories, anti–chromogranin A (1:300) was pur-
chased from Immunostar, anti-BrdU (1:200) was obtained from Novocas-
tra, and anti-Caspase3 (1:100) was purchased from Cell Signaling.
Analysis of stool hydration
To determine stool hydration, freshly isolated stool was weighted before 
and after overnight incubation at 50°C. Four mice of each genotype were 
analyzed. Mean and standard deviation values, as well as statistical sig-
niﬁ  cance (t test) were calculated using Excel (Microsoft).
Measurements of crypt diameter and of the number of BrdU-positive cells
Fields containing crypt transverse sections were selected randomly at several 
locations along the rostrocaudal axis of the small intestine. Only sections 
with several BrdU-positive cells and an apparent lumen were considered to 
avoid large variation in the position of the section in the crypt–villus axis. 
Six to nine ﬁ  elds, each containing 6–40 measured crypts, were analyzed 
by two individuals, who were blinded to the mouse genotypes, and two 
mice of each genotype were analyzed. Mean and standard deviation values, 
as well as statistical signiﬁ  cance (t test) were calculated using Excel.
Image acquisition and manipulation
Immunohistochemistry images were acquired at RT using either an Axio-
phot microscope (Carl Zeiss MicroImaging, Inc.) with 10× 0.3 Plan Neo-
ﬂ  uar or 40× 1.0 Plan Apochromat lenses (Carl Zeiss MicroImaging Inc.) 
and a camera (DXM1200; Nikon) or an Eclipse 80i microscope (Nikon) 
with Plan Fluor 10× 0.3, 20× 0.5, 40× 0.75, and 60× 0.5–1.25 
lenses (Nikon) and a camera (Q-Imaging Retiga 2000R with a Q-Imaging 
RGB Slider). Images were acquired with ACT-1 or Q-Capture Pro soft-
wares (Nikon) and manipulated with Photoshop (Adobe), using the crop, 
levels, curves, brightness/contrast, and image size commands. For acqui-
sition of immunoﬂ   uorescence experiments, an Axiophot2 (Carl Zeiss 
MicroImaging, Inc.) microscope was used with a 63× 1.4 Plan Apochromat 
objective (oil) and a Coolsnap (Photometrics) camera driven by the Meta-
vue software.
Online supplemental material
Fig. S1 shows Sox9 expression in Paneth cells fand a general view of a 
Sox9-deﬁ  cient colon, showing the localization and extent of the described 
phenotypic features. Fig. S2 provides an analysis of the goblet cell popula-
tion and of apoptosis rates in Sox9-deﬁ  cient mice. Fig. S3 shows β-catenin 
expression in Sox9-deﬁ  cient mice and consequences of Sox9 and ∆CSox9 
overexpression on the β-catenin–Tcf4 activity in a panel of colon carcinoma 
cell lines. Fig. S4 shows no modiﬁ   cation in the subcellular localization 
of β-catenin or Tcf4 or in the degradation of β-catenin after induction of 
Sox9 expression in the HT29Cl.16E-Sox9 cell line. Fig. S5 shows that in SOX9–WNT INTERACTION CONTROL INTESTINAL HOMEOSTASIS • BASTIDE ET AL. 647
Sox9-deﬁ  cient mice, the c-Myc and cyclin D1 genes are expressed by an 
increased number of cells, and individual cells express higher levels of the 
c-Myc and cyclin D1 proteins. Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.200704152/DC1.
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